aluates Reports

$ 0.0

Automative

Global GPCR-targeting Drug Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-22I14329

Global GPCR targeting Drug Market Research Report 2023

BUY CHAPTERS

Global GPCR-targeting Drug Market Research Report 2025

Code: QYRE-Auto-22I14329

Report

April 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

PerkinElmer Inc

Thermo Fisher Scientific

Merck

BD Biosciences

Molecular Devices

Promega

Qiagen NV

Abcam

Corning Inc

DiscoveRx

Cisbio

GPCR-targeting Drug Market Size

The global market for GPCR-targeting Drug was valued at US$ 426 million in the year 2024 and is projected to reach a revised size of US$ 508 million by 2031, growing at a CAGR of 2.6% during the forecast period.

GPCR-targeting Drug Market

GPCRs or G protein-coupled receptors are proteins located on the cell surface that recognize extracellular substances and transmit signals across the cell membrane. GPCRs do this by activating guanine nucleotide-binding proteins (G protein) that are responsible for signal transduction inside the cell. The signal delivery is very important in various cellular responses including cell growth, gene transcription, post-translational changes, and communication with other cells. This brings on adjustments in the body to adapt to the environmental changes such as increased heart rate when feeling threatened or change in vision in response to dim light.

North American market for GPCR-targeting Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for GPCR-targeting Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for GPCR-targeting Drug in Oncology is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of GPCR-targeting Drug include PerkinElmer, Thermo Fisher Scientific, Merck, BD Biosciences, Molecular Devices, Promega, Qiagen, Abcam, Corning, Discoverx, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for GPCR-targeting Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GPCR-targeting Drug.

The GPCR-targeting Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GPCR-targeting Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the GPCR-targeting Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of GPCR-targeting Drug Market Report

Report Metric	Details
Report Name	GPCR-targeting Drug Market
Accounted market size in year	US$ 426 million
Forecasted market size in 2031	US$ 508 million
CAGR	2.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Reagent Test Kit Substrate
Segment by Application	Oncology Cardiovascular Central Nervous Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	PerkinElmer, Thermo Fisher Scientific, Merck, BD Biosciences, Molecular Devices, Promega, Qiagen, Abcam, Corning, Discoverx, Cisbio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GPCR-targeting Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is GPCR-targeting Drug Market growing?

Ans: The GPCR-targeting Drug Market witnessing a CAGR of 2.6% during the forecast period 2025-2031.

What is the GPCR-targeting Drug Market size in 2031?

Ans: The GPCR-targeting Drug Market size in 2031 will be US$ 508 million.

Who are the main players in the GPCR-targeting Drug Market report?

Ans: The main players in the GPCR-targeting Drug Market are PerkinElmer, Thermo Fisher Scientific, Merck, BD Biosciences, Molecular Devices, Promega, Qiagen, Abcam, Corning, Discoverx, Cisbio

What are the Application segmentation covered in the GPCR-targeting Drug Market report?

Ans: The Applications covered in the GPCR-targeting Drug Market report are Oncology, Cardiovascular, Central Nervous, Other

What are the Type segmentation covered in the GPCR-targeting Drug Market report?

Ans: The Types covered in the GPCR-targeting Drug Market report are Reagent Test Kit, Substrate

Recommended Reports

Targeted Therapy Drugs

Oncology & Cancer

Central Nervous Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global GPCR-targeting Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Reagent Test Kit

1.2.3 Substrate

1.3 Market by Application

1.3.1 Global GPCR-targeting Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Oncology

1.3.3 Cardiovascular

1.3.4 Central Nervous

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global GPCR-targeting Drug Market Perspective (2020-2031)

2.2 Global GPCR-targeting Drug Growth Trends by Region

2.2.1 Global GPCR-targeting Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 GPCR-targeting Drug Historic Market Size by Region (2020-2025)

2.2.3 GPCR-targeting Drug Forecasted Market Size by Region (2026-2031)

2.3 GPCR-targeting Drug Market Dynamics

2.3.1 GPCR-targeting Drug Industry Trends

2.3.2 GPCR-targeting Drug Market Drivers

2.3.3 GPCR-targeting Drug Market Challenges

2.3.4 GPCR-targeting Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top GPCR-targeting Drug Players by Revenue

3.1.1 Global Top GPCR-targeting Drug Players by Revenue (2020-2025)

3.1.2 Global GPCR-targeting Drug Revenue Market Share by Players (2020-2025)

3.2 Global GPCR-targeting Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by GPCR-targeting Drug Revenue

3.4 Global GPCR-targeting Drug Market Concentration Ratio

3.4.1 Global GPCR-targeting Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by GPCR-targeting Drug Revenue in 2024

3.5 Global Key Players of GPCR-targeting Drug Head office and Area Served

3.6 Global Key Players of GPCR-targeting Drug, Product and Application

3.7 Global Key Players of GPCR-targeting Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 GPCR-targeting Drug Breakdown Data by Type

4.1 Global GPCR-targeting Drug Historic Market Size by Type (2020-2025)

4.2 Global GPCR-targeting Drug Forecasted Market Size by Type (2026-2031)

5 GPCR-targeting Drug Breakdown Data by Application

5.1 Global GPCR-targeting Drug Historic Market Size by Application (2020-2025)

5.2 Global GPCR-targeting Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America GPCR-targeting Drug Market Size (2020-2031)

6.2 North America GPCR-targeting Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America GPCR-targeting Drug Market Size by Country (2020-2025)

6.4 North America GPCR-targeting Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe GPCR-targeting Drug Market Size (2020-2031)

7.2 Europe GPCR-targeting Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe GPCR-targeting Drug Market Size by Country (2020-2025)

7.4 Europe GPCR-targeting Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific GPCR-targeting Drug Market Size (2020-2031)

8.2 Asia-Pacific GPCR-targeting Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific GPCR-targeting Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific GPCR-targeting Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America GPCR-targeting Drug Market Size (2020-2031)

9.2 Latin America GPCR-targeting Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America GPCR-targeting Drug Market Size by Country (2020-2025)

9.4 Latin America GPCR-targeting Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa GPCR-targeting Drug Market Size (2020-2031)

10.2 Middle East & Africa GPCR-targeting Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa GPCR-targeting Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa GPCR-targeting Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 PerkinElmer

11.1.1 PerkinElmer Company Details

11.1.2 PerkinElmer Business Overview

11.1.3 PerkinElmer GPCR-targeting Drug Introduction

11.1.4 PerkinElmer Revenue in GPCR-targeting Drug Business (2020-2025)

11.1.5 PerkinElmer Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Details

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific GPCR-targeting Drug Introduction

11.2.4 Thermo Fisher Scientific Revenue in GPCR-targeting Drug Business (2020-2025)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 Merck

11.3.1 Merck Company Details

11.3.2 Merck Business Overview

11.3.3 Merck GPCR-targeting Drug Introduction

11.3.4 Merck Revenue in GPCR-targeting Drug Business (2020-2025)

11.3.5 Merck Recent Development

11.4 BD Biosciences

11.4.1 BD Biosciences Company Details

11.4.2 BD Biosciences Business Overview

11.4.3 BD Biosciences GPCR-targeting Drug Introduction

11.4.4 BD Biosciences Revenue in GPCR-targeting Drug Business (2020-2025)

11.4.5 BD Biosciences Recent Development

11.5 Molecular Devices

11.5.1 Molecular Devices Company Details

11.5.2 Molecular Devices Business Overview

11.5.3 Molecular Devices GPCR-targeting Drug Introduction

11.5.4 Molecular Devices Revenue in GPCR-targeting Drug Business (2020-2025)

11.5.5 Molecular Devices Recent Development

11.6 Promega

11.6.1 Promega Company Details

11.6.2 Promega Business Overview

11.6.3 Promega GPCR-targeting Drug Introduction

11.6.4 Promega Revenue in GPCR-targeting Drug Business (2020-2025)

11.6.5 Promega Recent Development

11.7 Qiagen

11.7.1 Qiagen Company Details

11.7.2 Qiagen Business Overview

11.7.3 Qiagen GPCR-targeting Drug Introduction

11.7.4 Qiagen Revenue in GPCR-targeting Drug Business (2020-2025)

11.7.5 Qiagen Recent Development

11.8 Abcam

11.8.1 Abcam Company Details

11.8.2 Abcam Business Overview

11.8.3 Abcam GPCR-targeting Drug Introduction

11.8.4 Abcam Revenue in GPCR-targeting Drug Business (2020-2025)

11.8.5 Abcam Recent Development

11.9 Corning

11.9.1 Corning Company Details

11.9.2 Corning Business Overview

11.9.3 Corning GPCR-targeting Drug Introduction

11.9.4 Corning Revenue in GPCR-targeting Drug Business (2020-2025)

11.9.5 Corning Recent Development

11.10 Discoverx

11.10.1 Discoverx Company Details

11.10.2 Discoverx Business Overview

11.10.3 Discoverx GPCR-targeting Drug Introduction

11.10.4 Discoverx Revenue in GPCR-targeting Drug Business (2020-2025)

11.10.5 Discoverx Recent Development

11.11 Cisbio

11.11.1 Cisbio Company Details

11.11.2 Cisbio Business Overview

11.11.3 Cisbio GPCR-targeting Drug Introduction

11.11.4 Cisbio Revenue in GPCR-targeting Drug Business (2020-2025)

11.11.5 Cisbio Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

PerkinElmer Inc

Thermo Fisher Scientific

Merck

BD Biosciences

Molecular Devices

Promega

Qiagen NV

Abcam

Corning Inc

DiscoveRx

Cisbio

List of Tables

Table 1. Global GPCR-targeting Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Reagent Test Kit

Table 3. Key Players of Substrate

Table 4. Global GPCR-targeting Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global GPCR-targeting Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global GPCR-targeting Drug Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global GPCR-targeting Drug Market Share by Region (2020-2025)

Table 8. Global GPCR-targeting Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global GPCR-targeting Drug Market Share by Region (2026-2031)

Table 10. GPCR-targeting Drug Market Trends

Table 11. GPCR-targeting Drug Market Drivers

Table 12. GPCR-targeting Drug Market Challenges

Table 13. GPCR-targeting Drug Market Restraints

Table 14. Global GPCR-targeting Drug Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global GPCR-targeting Drug Market Share by Players (2020-2025)

Table 16. Global Top GPCR-targeting Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GPCR-targeting Drug as of 2024)

Table 17. Ranking of Global Top GPCR-targeting Drug Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by GPCR-targeting Drug Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of GPCR-targeting Drug, Headquarters and Area Served

Table 20. Global Key Players of GPCR-targeting Drug, Product and Application

Table 21. Global Key Players of GPCR-targeting Drug, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global GPCR-targeting Drug Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global GPCR-targeting Drug Revenue Market Share by Type (2020-2025)

Table 25. Global GPCR-targeting Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global GPCR-targeting Drug Revenue Market Share by Type (2026-2031)

Table 27. Global GPCR-targeting Drug Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global GPCR-targeting Drug Revenue Market Share by Application (2020-2025)

Table 29. Global GPCR-targeting Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global GPCR-targeting Drug Revenue Market Share by Application (2026-2031)

Table 31. North America GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America GPCR-targeting Drug Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America GPCR-targeting Drug Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe GPCR-targeting Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe GPCR-targeting Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific GPCR-targeting Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific GPCR-targeting Drug Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific GPCR-targeting Drug Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America GPCR-targeting Drug Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America GPCR-targeting Drug Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa GPCR-targeting Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa GPCR-targeting Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa GPCR-targeting Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. PerkinElmer Company Details

Table 47. PerkinElmer Business Overview

Table 48. PerkinElmer GPCR-targeting Drug Product

Table 49. PerkinElmer Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)

Table 50. PerkinElmer Recent Development

Table 51. Thermo Fisher Scientific Company Details

Table 52. Thermo Fisher Scientific Business Overview

Table 53. Thermo Fisher Scientific GPCR-targeting Drug Product

Table 54. Thermo Fisher Scientific Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)

Table 55. Thermo Fisher Scientific Recent Development

Table 56. Merck Company Details

Table 57. Merck Business Overview

Table 58. Merck GPCR-targeting Drug Product

Table 59. Merck Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)

Table 60. Merck Recent Development

Table 61. BD Biosciences Company Details

Table 62. BD Biosciences Business Overview

Table 63. BD Biosciences GPCR-targeting Drug Product

Table 64. BD Biosciences Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)

Table 65. BD Biosciences Recent Development

Table 66. Molecular Devices Company Details

Table 67. Molecular Devices Business Overview

Table 68. Molecular Devices GPCR-targeting Drug Product

Table 69. Molecular Devices Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)

Table 70. Molecular Devices Recent Development

Table 71. Promega Company Details

Table 72. Promega Business Overview

Table 73. Promega GPCR-targeting Drug Product

Table 74. Promega Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)

Table 75. Promega Recent Development

Table 76. Qiagen Company Details

Table 77. Qiagen Business Overview

Table 78. Qiagen GPCR-targeting Drug Product

Table 79. Qiagen Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)

Table 80. Qiagen Recent Development

Table 81. Abcam Company Details

Table 82. Abcam Business Overview

Table 83. Abcam GPCR-targeting Drug Product

Table 84. Abcam Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)

Table 85. Abcam Recent Development

Table 86. Corning Company Details

Table 87. Corning Business Overview

Table 88. Corning GPCR-targeting Drug Product

Table 89. Corning Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)

Table 90. Corning Recent Development

Table 91. Discoverx Company Details

Table 92. Discoverx Business Overview

Table 93. Discoverx GPCR-targeting Drug Product

Table 94. Discoverx Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)

Table 95. Discoverx Recent Development

Table 96. Cisbio Company Details

Table 97. Cisbio Business Overview

Table 98. Cisbio GPCR-targeting Drug Product

Table 99. Cisbio Revenue in GPCR-targeting Drug Business (2020-2025) & (US$ Million)

Table 100. Cisbio Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. GPCR-targeting Drug Picture

Figure 2. Global GPCR-targeting Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global GPCR-targeting Drug Market Share by Type: 2024 VS 2031

Figure 4. Reagent Test Kit Features

Figure 5. Substrate Features

Figure 6. Global GPCR-targeting Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global GPCR-targeting Drug Market Share by Application: 2024 VS 2031

Figure 8. Oncology Case Studies

Figure 9. Cardiovascular Case Studies

Figure 10. Central Nervous Case Studies

Figure 11. Other Case Studies

Figure 12. GPCR-targeting Drug Report Years Considered

Figure 13. Global GPCR-targeting Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global GPCR-targeting Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global GPCR-targeting Drug Market Share by Region: 2024 VS 2031

Figure 16. Global GPCR-targeting Drug Market Share by Players in 2024

Figure 17. Global Top GPCR-targeting Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GPCR-targeting Drug as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by GPCR-targeting Drug Revenue in 2024

Figure 19. North America GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America GPCR-targeting Drug Market Share by Country (2020-2031)

Figure 21. United States GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe GPCR-targeting Drug Market Share by Country (2020-2031)

Figure 25. Germany GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific GPCR-targeting Drug Market Share by Region (2020-2031)

Figure 33. China GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America GPCR-targeting Drug Market Share by Country (2020-2031)

Figure 41. Mexico GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa GPCR-targeting Drug Market Share by Country (2020-2031)

Figure 45. Turkey GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE GPCR-targeting Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. PerkinElmer Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)

Figure 49. Thermo Fisher Scientific Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)

Figure 50. Merck Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)

Figure 51. BD Biosciences Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)

Figure 52. Molecular Devices Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)

Figure 53. Promega Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)

Figure 54. Qiagen Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)

Figure 55. Abcam Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)

Figure 56. Corning Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)

Figure 57. Discoverx Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)

Figure 58. Cisbio Revenue Growth Rate in GPCR-targeting Drug Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global GPCR Assay Services Market Research Report 2025

Global GPCR Assay Kit Market Research Report 2024

G protein Coupled Receptor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Melanocortin Receptor Agonist Drugs Market Research Report 2024

Global 5 Hydroxytryptamine Receptor Market Research Report 2025

Global GPCR Screening Market Research Report 2025

Global Muscarinic Acetylcholine Receptor Market Research Report 2025

Global Targeting Peptides Market Research Report 2024

Global Gamma Aminobutyric Acid GABA Receptor Market Research Report 2024

Global GPCR Screening Service Market Research Report 2025

Global Estrogen Receptor Agonist Market Research Report 2025

Global Cell Signaling Market Research Report 2024

Opioid Receptor Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global GLP 1 Peptide Drugs Market Research Report 2024

Global Tumor Targeting Peptides Market Research Report 2024

Global Melanocortin Agonist Market Research Report 2024

Global Growth Factors and Cytokines Market Research Report 2024

Global GalNAc based Drug Market Research Report 2024

LGR5 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions